Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.

Abstract:

:Tissue inhibitor of metalloproteinases-1 (TIMP-1), the major physiological matrix metalloproteinase inhibitor and a potent antimetastatic factor, also stimulates the growth of erythroid progenitors (erythroid-potentiating activity). We analyzed the relationship between the growth factor activity and protease inhibition by preparing purified TIMP-1 "knockout" proteins lacking in vitro antiproteolytic activity. The growth-stimulatory effect of these N-terminal TIMP-1 point mutants, as tested in an in vitro assay using erythroid precursors (erythroid burst-forming units) was equal to that of unmutated TIMP-1. A fully antiproteolytic C-terminal TIMP-1 truncation also stimulated growth in the erythroid burst-forming unit assay. The results indicate that the influence of TIMP-1 on erythroid precursor growth is independent of its ability to inhibit metalloproteinases. TIMP-1 is analogous to proteins that have both proteolytic and growth factor activity, such as plasmin, thrombin, and urokinase. However, TIMP-1 is novel in this regard because it is a metalloproteinase inhibitor. We show that the antiproteolytic and growth factor activities of the TIMP-1 molecule are physically and functionally distinct.

journal_name

Blood

journal_title

Blood

authors

Chesler L,Golde DW,Bersch N,Johnson MD

subject

Has Abstract

pub_date

1995-12-15 00:00:00

pages

4506-15

issue

12

eissn

0006-4971

issn

1528-0020

journal_volume

86

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells.

    abstract::Activation of the mitogen-activated protein (MAP) kinase pathway has been associated with both cell proliferation and differentiation. Constitutively activated forms of Mek (MAP kinase/Erk kinase) and Erk (MAP kinase) have been previously shown capable of inducing differentiation or proliferation in nonhematopoietic c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Melemed AS,Ryder JW,Vik TA

    更新日期:1997-11-01 00:00:00

  • Total folate binding capacity of normal human plasma, and variations in uremia, cirrhosis, and pregnancy.

    abstract::The current study presents evidence that all human serum contains a class of high-affinity folate binders (KA=2.8 X10(10 liters/mole), which migrate as a single peak on gel filtration. Failure of previous studies to detect this characteristic in all but a minority of subjects is attributable to its variable, often tot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Colman N,Herbert V

    更新日期:1976-12-01 00:00:00

  • Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction.

    abstract::In search of a possible involvement of the human herpesvirus type 6 (HHV-6) in human Hodgkin's and non-Hodgkin's lymphomas, we studied the levels of anti-HHV-6 antibodies in the sera of 94 cases by an immunofluorescence assay, as well as the presence of HHV-6 sequences in the affected tissues of 66 cases by polymerase...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Torelli G,Marasca R,Luppi M,Selleri L,Ferrari S,Narni F,Mariano MT,Federico M,Ceccherini-Nelli L,Bendinelli M

    更新日期:1991-05-15 00:00:00

  • Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis.

    abstract::The zinc finger transcription factor GATA-2 is highly expressed in immature hematopoietic cells and declines with blood cell maturation. To investigate its role in normal adult hematopoiesis, a bicistronic retroviral vector encoding GATA-2 and the green fluorescent protein (GFP) was used to maintain the high levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Persons DA,Allay JA,Allay ER,Ashmun RA,Orlic D,Jane SM,Cunningham JM,Nienhuis AW

    更新日期:1999-01-15 00:00:00

  • Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

    abstract::Fibrin is essential for hemostasis; however, abnormal fibrin formation is hypothesized to increase thrombotic risk. We previously showed that in situ thrombin generation on a cell's surface modulates the 3-dimensional structure and stability of the fibrin network. Currently, we compared the abilities of extravascular ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-06-228940

    authors: Campbell RA,Overmyer KA,Selzman CH,Sheridan BC,Wolberg AS

    更新日期:2009-11-26 00:00:00

  • Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.

    abstract::Over the past few years, substantial advances have been made in understanding the pathogenesis, evolution, and complexity of mast cell neoplasms. New diagnostic and prognostic parameters and novel therapeutic targets with demonstrable clinical impact have been identified. Several of these new markers, molecular target...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-09-731893

    authors: Valent P,Akin C,Metcalfe DD

    更新日期:2017-03-16 00:00:00

  • Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.

    abstract::Primary infection with the human herpesvirus, Epstein-Barr virus (EBV), may result in subclinical seroconversion or may appear as infectious mononucleosis (IM), a lymphoproliferative disease of variable severity. Why primary infection manifests differently between patients is unknown, and, given the difficulties in id...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.13.3739

    authors: Silins SL,Sherritt MA,Silleri JM,Cross SM,Elliott SL,Bharadwaj M,Le TT,Morrison LE,Khanna R,Moss DJ,Suhrbier A,Misko IS

    更新日期:2001-12-15 00:00:00

  • Acute hyperviscosity: syndromes and management.

    abstract::Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients w...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-06-846816

    authors: Gertz MA

    更新日期:2018-09-27 00:00:00

  • Donor origin of multipotent adult progenitor cells in radiation chimeras.

    abstract::Multipotent adult progenitor cells (MAPCs) are bone marrow-derived stem cells that have extensive in vitro expansion capacity and can differentiate in vivo and in vitro into tissue cells of all 3 germinal layers: ectoderm, mesoderm, and endoderm. The origin of MAPCs within bone marrow is unknown. MAPCs are believed to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4603

    authors: Reyes M,Li S,Foraker J,Kimura E,Chamberlain JS

    更新日期:2005-11-15 00:00:00

  • Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.

    abstract::Dendritic cells (DCs) are specialized antigen-presenting cells that monitor the antigenic environment and activate naive T cells. The role of DCs is not only to sense danger but also to tolerize the immune system to antigens encountered in the absence of maturation/inflammatory stimuli. Indeed, if a naive T cell encou...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1211

    authors: Levings MK,Gregori S,Tresoldi E,Cazzaniga S,Bonini C,Roncarolo MG

    更新日期:2005-02-01 00:00:00

  • Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.

    abstract::Approximately 60% of patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL) are curable with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemoimmunotherapy. Epratuzumab (E) is an unlabeled anti-CD22 monoclonal antibody with efficacy in relapsed DLBCL. This phase 2 trial te...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-02-336990

    authors: Micallef IN,Maurer MJ,Wiseman GA,Nikcevich DA,Kurtin PJ,Cannon MW,Perez DG,Soori GS,Link BK,Habermann TM,Witzig TE

    更新日期:2011-10-13 00:00:00

  • A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.

    abstract::A 42-yr-old woman with systemic lupus erythematosus without bleeding diathesis developed a prolonged activated partial thromboplastin time that was not corrected by normal plasma. An inhibitor that acted rapidly and inactivated 0.5 U/ml plasma thromboplastin antecedent (PTA, factor XI) at a 1:200 plasma dilution was d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poon MC,Saito H,Koopman WJ

    更新日期:1984-06-01 00:00:00

  • Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

    abstract::Serum from 398 myeloma patients at diagnosis and serial samples from 29 patients were analysed for hepatocyte growth factor (HGF). HGF was elevated at diagnosis in 43% of myeloma patients compared with healthy controls (median 1.00 ng/mL and 0.44 ng/mL, respectively; P < .00001). In the group with elevated HGF levels ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Seidel C,Børset M,Turesson I,Abildgaard N,Sundan A,Waage A

    更新日期:1998-02-01 00:00:00

  • Molecular insights into regulation of JAK2 in myeloproliferative neoplasms.

    abstract::The critical role of Janus kinase-2 (JAK2) in regulation of myelopoiesis was established 2 decades ago, but identification of mutations in the pseudokinase domain of JAK2 in myeloproliferative neoplasms (MPNs) and in other hematologic malignancies highlighted the role of JAK2 in human disease. These findings have revo...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2015-01-621110

    authors: Silvennoinen O,Hubbard SR

    更新日期:2015-05-28 00:00:00

  • A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo.

    abstract::For activation T cells engage antigen-presenting cells (APCs) in lymphatic tissues. The contact duration and kinetics (static versus dynamic) vary considerably in different model systems; however, it is unclear whether T cells, APCs, or the environment are responsible for the observed discrepancies. Using 3-D collagen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1193

    authors: Gunzer M,Weishaupt C,Hillmer A,Basoglu Y,Friedl P,Dittmar KE,Kolanus W,Varga G,Grabbe S

    更新日期:2004-11-01 00:00:00

  • Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.

    abstract::Successful allogeneic hematopoietic stem cell transplantation (HSCT) requires reconstitution of normal T-cell immunity. Recipient thymic activity, biologic features of the allograft, and preparative regimens all contribute to immune reconstitution. We evaluated circulating T-cell phenotypes and T-cell receptor rearran...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lewin SR,Heller G,Zhang L,Rodrigues E,Skulsky E,van den Brink MR,Small TN,Kernan NA,O'Reilly RJ,Ho DD,Young JW

    更新日期:2002-09-15 00:00:00

  • Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.

    abstract::We report the outcome of allogeneic bone marrow transplantation (BMT) as treatment for severe combined immunodeficiency disease (SCID) in 31 patients grafted from 1968 until 1992. The patients received a graft from an HLA-identical related (n = 10), an HLA-haplo-identical related (n = 19), or a closely HLA-matched unr...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: van Leeuwen JE,van Tol MJ,Joosten AM,Schellekens PT,van den Bergh RL,Waaijer JL,Oudeman-Gruber NJ,van der Weijden-Ragas CP,Roos MT,Gerritsen EJ

    更新日期:1994-12-01 00:00:00

  • Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia.

    abstract::Donor lymphocyte infusions have been effective in patients with chronic myeloid leukemia (CML) relapsing after allogeneic stem cell transplantation, but their use is associated with the risk of graft-versus-host disease. We investigated the effects of prophylactic infusion of in vitro-generated donor T cells reactive ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-308569

    authors: Bornhäuser M,Thiede C,Platzbecker U,Kiani A,Oelschlaegel U,Babatz J,Lehmann D,Hölig K,Radke J,Tuve S,Wermke M,Wehner R,Jähnisch H,Bachmann MP,Rieber EP,Schetelig J,Ehninger G,Schmitz M

    更新日期:2011-06-30 00:00:00

  • c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid.

    abstract::We have analyzed the reactivation of fetal hemoglobin (HbF) synthesis under rigorous in vitro conditions, ie, in mature erythroblasts generated by erythroid burst-forming units (BFU-E) stringently purified from normal adult peripheral blood and grown in fetal calf serum(FCS)-free semisolid or liquid phase culture. In ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Peschle C,Gabbianelli M,Testa U,Pelosi E,Barberi T,Fossati C,Valtieri M,Leone L

    更新日期:1993-01-15 00:00:00

  • HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.

    abstract::Hypoxia-inducible factor-1α (HIF1α), a master transcriptional regulator of the cellular and systemic hypoxia response, is essential for the maintenance of self-renewal capacity of normal HSCs. It is still unknown whether HIF1α has a role in survival regulation of leukemia stem cells (LSCs) in chronic myeloid leukemia ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387381

    authors: Zhang H,Li H,Xi HS,Li S

    更新日期:2012-03-15 00:00:00

  • Induction of proliferation and blast transformation by interferon in human malignant and non-malignant lymph node B cells.

    abstract::The influence of interferon (IFN) on cellular proliferation, blast transformation, and differentiation was studied in lymph node cells from 17 patients with B-cell lymphomas, one patient with T-cell lymphoma, and eight patients with enlarged, non-malignant lymph nodes. The effects of IFN on lymph node cells were compa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ostlund L,Biberfeld P,Robèrt KH,Christensson B,Einhorn S

    更新日期:1989-06-01 00:00:00

  • Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.

    abstract::Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive malignancy derived from precursors of plasmacytoid dendritic cells. We analyzed 21 cases with array-based comparative genomic hybridization (aCGH). Complete or partial chromosomal losses largely outnumbered the gains, with common deleted reg...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-337501

    authors: Lucioni M,Novara F,Fiandrino G,Riboni R,Fanoni D,Arra M,Venegoni L,Nicola M,Dallera E,Arcaini L,Onida F,Vezzoli P,Travaglino E,Boveri E,Zuffardi O,Paulli M,Berti E

    更新日期:2011-10-27 00:00:00

  • Splenic CD19-CD35+B220+ cells function as an inducer of follicular dendritic cell network formation.

    abstract::Follicular dendritic cells (FDCs) form a reticular FDC network in the lymphoid follicle that is essential for the retention and presentation of native antigens in the form of antigen-antibody immune complexes (ICs) to B cells during secondary immune response. Although the presence of migrating precursors of FDCs has b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-068387

    authors: Murakami T,Chen X,Hase K,Sakamoto A,Nishigaki C,Ohno H

    更新日期:2007-08-15 00:00:00

  • Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission.

    abstract::The translocation between chromosomes 8 and 21, t(8;21) (q22;q22), is the most frequent abnormality in acute myeloid leukemia (AML) with French-American-British type M2 (FAB-M2) morphology. The breakpoints in this translocation have been characterized at the molecular level, and the genes involved are AML1 on chromoso...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nucifora G,Larson RA,Rowley JD

    更新日期:1993-08-01 00:00:00

  • Role of stromal cells and macrophages in fibronectin biosynthesis and matrix assembly in human long-term marrow cultures.

    abstract::Fibronectin is a major component of the extracellular matrix of adherent layers of human long-term marrow cultures where it may stabilize the extracellular matrix network and provide adhesion sites for primitive hemopoietic cells. This study was devised to analyze the role of adherent cell populations in fibronectin s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lerat H,Lissitzky JC,Singer JW,Keating A,Herve P,Charbord P

    更新日期:1993-09-01 00:00:00

  • STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation.

    abstract::Fcgamma receptors (FcgammaRs) on mononuclear phagocytes trigger autoantibody and immune complex-induced diseases through coupling the self-reactive immunoglobulin G (IgG) response to innate effector pathways, such as phagocytosis, and the recruitment of inflammatory cells. FcRgamma-based activation is critical in the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-158477

    authors: Braun A,Gessner JE,Varga-Szabo D,Syed SN,Konrad S,Stegner D,Vögtle T,Schmidt RE,Nieswandt B

    更新日期:2009-01-29 00:00:00

  • Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.

    abstract::All-trans retinoic acid (ATRA) is an essential component of the treatment of acute promyelocytic leukemia (APL), but the optimal timing and duration remain to be determined. Molecular characterization of this disease can refine the diagnosis and could be potentially useful in monitoring response to treatment. Patients...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Burnett AK,Grimwade D,Solomon E,Wheatley K,Goldstone AH

    更新日期:1999-06-15 00:00:00

  • Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors.

    abstract::To analyze the structure of the murine erythropoietin receptor (EpoR), wild-type or mutant EpoR cDNAs were expressed in cell lines, and the proteins that cross-linked with 125I-labeled erythropoietin (Epo) were analyzed by immunoprecipitation using an antibody against the intracellular region of the cloned EpoR. COS-7...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miura O,Ihle JN

    更新日期:1993-04-01 00:00:00

  • Antibody-mediated marrow failure after allogeneic bone marrow transplantation.

    abstract::Marrow graft failure observed in association with histocompatibility differences between donor and recipient is often attributed to rejection mediated by host-derived cytolytic T lymphocytes. The data presented in this report indicate that persistent host antibodies specific for donor antigen may also mediate graft fa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barge AJ,Johnson G,Witherspoon R,Torok-Storb B

    更新日期:1989-10-01 00:00:00

  • Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways.

    abstract::When overexpressed in primary erythroid progenitors, oncogenic Ras leads to the constitutive activation of its downstream signaling pathways, severe block of terminal erythroid differentiation, and cytokine-independent growth of primary erythroid progenitors. However, whether high-level expression of oncogenic Ras is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047050

    authors: Zhang J,Liu Y,Beard C,Tuveson DA,Jaenisch R,Jacks TE,Lodish HF

    更新日期:2007-06-15 00:00:00